Travel: Chikungunya, Zika,.. New worries

Similar documents
Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018

What s Lurking out there??????

ZIKA VIRUS. John J. Russell MD May 27, 2016

Zika Virus Guidance for Medical Providers. Denise Smith, PHN, MPA Director of Disease Control Kern County Public Health Services Department

Zika Virus Update for Emergency Care Providers

Zika Virus: The Olympics and Beyond

An Introduction to Dengue, Zika and Chikungunya Viruses

Zika virus infection Interim clinical guidance for Primary Care

Zika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS

Zika Virus. ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. FLAVIVIRIDAE VIRUS SPECTRUM. Virus family Flaviviridae

This memo is intended to provide information to NC clinicians and laboratories regarding diagnosis, management and reporting of Zika virus infection.

Module Three About Zika Virus: What is Known and Not Known

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

Zika Virus. Centers for Disease Control and Prevention

Zika Virus. Maternal & Fetal Effects. John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona

2017 SCAAP Summer Conference. Lilian Peake, MD, MPH

Zika Virus What Every Woman Needs to Know

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa

Zika Virus Update. Partner Webinar 05/12/2016

ZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

Zika Virus and Prevention in Mississippi

What is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada?

Zika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas

Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016

Mosquito Control Update. Board of County Commissioners Work Session February 16, 2016

THE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group

When infections go viral Zika Virus

European Centre for Disease Prevention and Control. Zika virus disease

Presentation Overview

Zika Virus and Control Efforts in Arizona

Guidance for Investigation and Management of Zika Virus Infection

Zika Virus in the Primary Care Setting

ZIKA VIRUS. Epic and aspects of management

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

What is Zika virus (Zika)?

Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016

Zika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County

ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates

Testing - Pregnant Women

Wrapping Our Heads Around the Outbreak

Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know

Zika virus: a new global threat for Dr Gina McAllister Clinical Scientist, Virology

Mercer MRC A Newsletter for and about our volunteers

Epidemiology and entomology of the Zika virus outbreak

Zika Virus Basics. Flaviviridae Flavivirus Disease Vector Vaccine *Dengue (serotypes 1-4) Zika Virus Basics. Zika Virus Transmission Cycle

Zika Virus. Lee Green Vector-Borne Epidemiologist Indiana State Department of Health. April 13, 2016

Everything you ever wanted to know about Zika Virus Disease

Vector-Borne Diseases Update: Maricopa County

Microbes at Our Doorstep: Emerging issues in infection control and travel-related infections

SPECIALIZED FAMILY CARE Provider Training

3/24/2017. CDC S Response to Zika ZIKA 101. Updated February 2, 2017 INTRODUCTION

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016

Zika Virus. Division of Infectious Disease Department of Internal Medicine Global Health Program Conference Dora Lebron, MD Alexandra Stang, MD

Zika Virus. Robert Wittler, MD

Zika Virus. Disclosure. Zika Virus 8/26/2016

General Description. Significance

Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses

ZIKA COLLABORATION MEETING: CLINICAL PERSPECTIVE. Julius L. Tonzel Vector-borne Diseases Epidemiologist Louisiana Office of Public Health

Annual Epidemiological Report

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

Zika Virus A Public Health Emergency of Olympic Proportions

What You Need to Know ZIKA VIRUS

Zika Virus: Epidemiology and Preparedness NH Emergency Preparedness Conference June 9, 2016

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities

KILLER BITES: Mosquito-Borne Viruses Jon Mark Hirshon, MD, MPH, PhD

ZIKA VIRUS TESTING GUIDANCE, UPDATED 7/20/2016

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay. September 7, 2016

Surveillance Protocol Dengue Fever (Breakbone fever, Dengue Hemorrhagic Fever)

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Where is Yellow Fever found?

ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES

Updated Information Zika Virus Testing Guidelines

Quarte. FOCUS: Zika. March Volume. Zika Virus. is present. reached. can cause. low, with. in the

ZIKA PRESENTED BY DENNIS QUERTERMOUS, DIANNA HUNTER, MERCEDES RUTLEDGE, AND DRE'ANDRIA THOMPSON

Mosquito Control Matters

CHIKUNGUNYA VIRUS INFECTION. Cesar Ponce S. Medical Microbiologist and Parasitologist. Epidemiologist ADC Medical Microbiology Department Director

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

CDC Responds to ZIKA Zika 101

Zika Preparedness: Lessons for the U.S. Public Health System

Zika virus: clinical and epidemiological features

Geographic distribution ZIKV

Alberta Health Public Health Notifiable Disease Management Guidelines March 2017

Fact Sheet. Zika Virus

ZIKA AND MOSQUITO- BORNE ILLNESSES

Zika and Emerging Infectious Diseases. Clifford T. Mauriello, MD, FAAP Assistant Clinical Professor May 31, 2016

Zika Virus Dr Conor Doherty

Arboviruses in Florida. Carina Blackmore, DVM, PhD Florida Department of Health Bureau of Environmental Public Health Medicine

Zika Virus Outbreak An Update and Overview of the New York State Response

Seroprevalence and Recent Trends of Dengue in a Rural Area in South India

Fight the Bite Zika Virus Webinar District of Columbia Department of Health

Emerging TTIs How Singapore secure its blood supply

Zika Update. Florida Department of Health Broward. Paula Thaqi, MD, MPH Director

Mosquito Threats in LA County West Nile virus & Zika

AAP ZIKA ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES)

Zika 101 for Occupational Safety and Health Professionals

Transcription:

Travel: Chikungunya, Zika,.. New worries McGill Family Physician Refresher Course Dec 6, 2016 Makeda Semret, MD FRCP(C) Infectious Diseases/ Medical Microbiology

Disclosures Funding from PHAC/CIHR/GSK/Novartis for influenza surveillance in Montreal In-kind research support from biomerieux for work on Hospital-Associated Infections in Africa (Ethiopia) No speaking or consultancy fees from industry 2

Objectives Know when to suspect an arboviral (arthropod-borne virus) infection in travelers and common clinical scenarios Know what laboratory tests to send and the limitations of these tests Know current guidelines for management of Zika exposure, and available resources 3

37 year old female, previously healthy Presents to your clinic with fever, myalgias, malaise, lethargy x 3 days. Returned 12 days ago from one week stay in Haiti No localising signs and symptoms Temp 38.2 0 C, BP 120/80, HR 108, RR 20 Looks unwell but not toxic Cardiac, Resp, Abdo, MSK: unremarkable WBC 3.0 (lymphs 1.0); Plt 95; Hb 122 4

Your working diagnosis? Further investigations? Further management? 5

Fever from the tropics leading life-threatening illness The No. 1 life threatening infection for travelers about 30,000 European and N. American travelers infected annually,?150 die 4% mortality (P.f.); 20% in severe cases Am J Trop Med Hyg 2013;88:397 404. 6

Malaria in travellers leading life-threatening illness Am J Trop Med Hyg 2013;88:397 404. 7

First Key Message In a febrile patient from the tropics, always rule out malaria (and bacterial sepsis) - TODAY. You cannot (in Canada) make a firm diagnosis of an arboviral infection on the first visit. 8

Second Key Message: Geography! Ann Intern Med. 2013;158:456-468 9

Third message: things change!! Chikungunya Dec 2013 Chikungunya Dec 2014 10

Things change.. 11

Why do (did) these diseases spread? Some of these viruses can be transmitted human to human but not a preferred route, and therefore relatively low risk E.g., sexual transmission of Zika virus Spread of these diseases follow the distribution of the vector (the mosquitoe) Distribution influenced by climactic changes and vector adaptation 12

Vectors for Transmission for Dengue, Chikungunya, Zika: Aedes sp Day feeders; once infected, mosquitoes stay infected for life (30-45d) Also responsible for Yellow Fever transmission! Aedes aegyptii Aedes albopictus 13

Adaptation of the vector Slide courtesy of Dr M. Libman

Societal changes: uncontrolled urbanization Slide courtesy of M. Libman

World Wide Distribution of Aedes aegypti elife 2015;4:e08347, accessed Nov 19, 2016 16

The viruses Dengue and Zika are flaviviruses Same family as Yellow Fever, West Nile, Japanese encephalitis They can cross-react in serological tests (! vaccinees) Chikungunya is an alphavirus Same family as Mayaro, O'nyong'nyong, and others associated with encephalitis, arthritis syndromes No serological cross-reactions with dengue or zika 17

They initially present in much the same way Short Incubation (3-10d most frequently) Fever, myalgias, headache, malaise +/- rash: last 3-7 days Low WBC and Plts How do you differentiate? 18

First, worry about Dengue Frequent cause of fever in travelers from SE Asia and Central America/Caribbean. Can lead to severe illness with possible hemorrhagic fever (rare) --- you can't tell who will progress to severe disease until a good 72h after defervescence Monitor closely for warning signs 19

Warning signs Abdominal pain or tenderness Persistent vomiting Clinical fluid accumulation (ascites, effusions) Mucosal bleeding Lethargy/restlessness Liver enlargement > 2cm Hematocrit increase, rapid decrease in PLT Start at defervescence (D5-6) and last 48-72h 20

Manage (while waiting for diagnosis) Supportive treat symptoms but avoid NSAIDS if dengue still a possibility potential for bleeding Testing: serology (requesting serology for all 3 makes sense, but in practice dengue +/- chik first) Follow-up (at least by telephone) to ensure no progression If dengue: no long-term sequelae; also no life long immunity (at least 4 different serotypes) - so discuss risk of re-infection 21

Chikungunya "to walk bent up in makonde - nothing to do with chickens! Initial presentation like dengue More arthralgias/arthritis but often these occur later (after defervescence) - can lead to significant morbidity, other complications rare Immunity after infection is probably lifelong 22

Back to our patient Improves with symptomatic management A few days later tells you she has been trying to get pregnant She has no joint symptoms You are still waiting for her serology results.. 23

24

Zika beware what you think you know http://www.vox.com/2016/2/19/11062000/zika-virus-unknowns-questions 25

Zika beware what you think you know http://www.cdc.gov/zika/geo/active-countries.html accessed Oct 15 2016 26

Zika Infection typical clinical disease Incubation usually 2 to 14 days Resolves spontaneously Approx 80% asymptomatic http://www.goinvo.com/features/zika/

Zika Infection vertical transmission Vertical transmission Est. Risk of microcephaly from Zika infection in T1 = 1-13% First time we face infectious epidemic teratogen since rubella Neither pre-2007 Asian nor African lineages directly implicated with congenital Zika syndrome or neurologic illness (unnoticed vs different bio?) http://www.goinvo.com/features/zika/

Zika Infection sexual transmission Human cases Confirmed in 9 nonendemic countries and 3 endemic countries High endemic F:M ratio suggests it s common Vaginal, oral, anal sex Mostly M F even without symptoms RNA persistance Fluid Typical Record Blood* 7-14d * 81d* Urine 14 Saliva? (no known transm) Semen? 188d (culture -) Vaginal secretions? 14 Breats milk (only 1 case of live virus, no transm reported)?? 69d (culture +) http://www.goinvo.com/features/zika/

Precautions/prevention for zika? Since many infections are asymptomatic : travellers to endemic area and who want to eventually conceive should have protected sex (or abstain) for: 6 months for Men; 2 months for Women (CDC and PHAC) 6 months for both (WHO) Barrier precautions for duration of pregnancy if already pregnant http://healthycanadians.gc.ca/diseases-conditions-maladiesaffections/disease-maladie/zika-virus/prevention-eng.php ttps://www.cdc.gov/zika/prevention/protect-yourself-during-sex.html http://www.who.int/csr/disease/zika/information-for-travelers/en 30

Who to test? Any pregnant woman who has been in an area with Zika: If symptomatic and within 14 days of symptoms send both PCR of blood+urine AND serology If no symptoms (or > 14 days since symptoms): send serology (PRNT will be done if IgM positive) If >12 weeks since trip or symptoms, do not send (false negatives), but recommend to follow ultrasound Ultrasound within 4 weeks of exposure and q 4 weeks until lab results 31

Important details on testing Testing will be rejected by provincial lab unless details of travel (dates, place) and symptoms (with dates) are provided legibly on the requisition. You can test Men if specify "wishing to conceive, pregnant partner, adding epidemiological info (area, dates of travel) 32

Zika in Canada As of 30 Sept 2016: 328 travel associated cases 2 sexually transmitted cases 2 maternal fetal transmissions 14 pregnant women Outcome available for 2 only one with Zika associated abnormalities, one without 33

Counselling for our patient What would you advise her pending results? What would you advise if she had been asymptomatic? What if her Zika serology comes back negative? And if her partner had traveled with her? And if he had not traveled with her? 34

Many unanswered questions True risk of vertical transmission? By trimester? % of vertical transmission with clinical consequences? Importance of sexual transmission, and max duration of infectivity? Neurological complication rate for adults? Clinical differences between lineages? 35

Take home messages Don t forget malaria commonest life threatening cause of fever. Arboviruses are more frequent causes of fever in travelers from the Americas and SE Asia. Most are self limited Dengue can sometimes be life threatening Chikungunya can lead to chronic morbidity Zika is an issue for pregnancy 36

Take home messages (cont d) The results of tests for all these diseases take several weeks to become available; also issue of cross reactivity, so clinical and epidemiologic context is important PREVENTION: No vaccines for any! Day-biting mosquito-avoidance (DEET/ICARDIDIN; light-coloured clothing, wind, air conditioning) 37

Questions? J.D. MacLean Centre for Tropical Diseases https://www.mcgill.ca/tropmed/ Makeda.semret@mcgill.ca 38